AstraZeneca’s Q2 net profit rises on strong cancer drug sales

Have anything to say about this article?

You can report: fake news, misinformation, error, more information, additional data, etc.

Comment
Cancel
Your comment has been sent successfuly! Thank you.
Free Malaysia Today Malesia 1h

AstraZeneca’s Q2 net profit rises on strong cancer drug sales

AstraZeneca reconfirmed its full-year outlook after its Q2 profit beat analyst expectations. (EPA Images pic) LONDON: British pharmaceutical giant AstraZeneca on Monday said net profit rose in its second quarter (Q2), driven once again by strong growth in sales of its cancer drugs. Profit after tax»»»

freemalaysiatoday.com
Bangladesh Sangbad Sangstha Bangladesh 1h

AstraZeneca quarterly net profit rises on strong cancer drug sales

LONDON, July 27, 2026 (BSS/AFP) - British pharmaceutical giant AstraZeneca on Monday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs. Profit after tax climbed more than two percent to $2.5 billion in the three months to the end of June, co»»»

bssnews.net
The Times of India India 06.09.2025. 23:00

TN signs MoUs with Hinduja, AstraZeneca

Chennai: State govt represented by chief minister M K Stalin signed a memorandum of understanding (MoU) worth 7,500 crore with UK-based Hinduja Group toward investment in Tamil Nadu's EV ecosystem, focusing on battery storage systems. The MoU is expected to create more than 1,000 jobs. Soon after t»»»

timesofindia.indiatimes.com
The Peninsula Qatar 29.04.2025. 18:26

AstraZeneca moves some production to US amid tariff threat

London: British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector. "Our company is firmly committed to investing and growing in the US," chief executive P»»»

thepeninsulaqatar.com
Hindustan Times India 11.04.2025. 14:36

UK approves 'landmark' drug that helps slow spread of incurable breast cancer type

Scientists described the approval of capivasertib by the National Institute for Health and Care Excellence (NICE) as a "landmark moment". A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials s»»»

hindustantimes.com
Malay Mail Malesia 31.10.2024. 06:30

AstraZeneca confirms investigation of China operations president Leon Wang

SHANGHAI, Oct 31 — AstraZeneca said its China president Leon Wang is under investigation and the drugmaker would cooperate with Chinese authorities. The company did not say what the investigation was about or whether Wang has been detained by Chinese authorities. When asked about his whereabouts, a»»»

malaymail.com
United News of Bangladesh Bangladesh 18.05.2024. 11:33

Bangladesh seeks support of Oxford Vaccine Group to establish vaccine centre

Health Minister Dr Samanta Lal Sen has sought support from the Oxford Vaccine Group at the University of Oxford to establish a vaccine centre in Bangladesh. He recently visited the university where the AstraZeneca vaccine was developed during the Covid pandemic. During the visit, the minister met w»»»

unb.com.bd
The Guardian Gran Bretagna 11.04.2024. 10:19

AstraZeneca promises dividend rise hours before vote on boss’s £19m pay deal

Shareholders at AstraZeneca are in line for a 7% increase in dividends this year as the pharmaceutical company attempts to garner support for a pay deal worth up to £19m for its boss, Pascal Soriot. AstraZeneca said it intended to increase the annual dividend for 2024 by $0.20 to $3.10 a share, ref»»»

theguardian.com
Jordan Times Giordania 14.03.2024. 23:09

AstraZeneca buys French biotech firm Amolyt for $1b

LONDON — Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs. "AstraZeneca... has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotech»»»

Gulf News Emirati Arabi Uniti 14.03.2024. 11:54

AstraZeneca buys French biotech firm Amolyt for $1 billion

London: Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs. "AstraZeneca ... has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotech»»»

gulfnews.com
Have anything to say about this article?

You can report: fake news, misinformation, error, more information, additional data, etc.

Comment
Cancel
Your comment has been sent successfuly! Thank you.